153 filings
10-K
2023 FY
LTRN
Lantern Pharma Inc
Annual report
18 Mar 24
4:05pm
8-K
LTRN
Lantern Pharma Inc
18 Mar 24
Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights
4:05pm
SC 13D/A
Bios Equity Partners, LP
1 Mar 24
Lantern Pharma / Bios Equity Partners ownership change
4:10pm
4
BIOS Capital Management, LP
29 Feb 24
Lantern Pharma / Aaron G.L. Fletcher ownership change
9:54pm
4
Cavu Advisors, LLC
29 Feb 24
Lantern Pharma / Leslie W. Kreis ownership change
9:54pm
144
LTRN
Lantern Pharma Inc
28 Feb 24
Notice of proposed sale of securities
9:41pm
144
LTRN
Lantern Pharma Inc
28 Feb 24
Notice of proposed sale of securities
9:41pm
144
BIOS Fund II, LP
28 Feb 24
Notice of proposed sale of securities
9:40pm
SC 13G/A
LTRN
Lantern Pharma Inc
14 Feb 24
Lantern Pharma / ProPhase Labs ownership change
4:05pm
4
Bios Equity Partners II, LP
19 Jan 24
Lantern Pharma / Aaron G.L. Fletcher ownership change
4:31pm
4
Leslie W. Kreis
19 Jan 24
Lantern Pharma / Leslie W. Kreis ownership change
4:30pm
8-K
LTRN
Lantern Pharma Inc
29 Dec 23
Departure of Directors or Certain Officers
4:05pm
SC 13D/A
LTRN
Lantern Pharma Inc
1 Dec 23
Lantern Pharma / Bios Equity Partners ownership change
6:02am
4
BIOS Advisors GP, LLC
1 Dec 23
Lantern Pharma / Aaron G.L. Fletcher ownership change
6:01am
4
Cavu Management, LP
1 Dec 23
Lantern Pharma / Leslie W. Kreis ownership change
6:00am
8-K
LTRN
Lantern Pharma Inc
24 Nov 23
Entry into a Material Definitive Agreement
4:05pm
10-Q
2023 Q3
LTRN
Lantern Pharma Inc
Quarterly report
8 Nov 23
4:05pm
8-K
LTRN
Lantern Pharma Inc
8 Nov 23
Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights
4:05pm
8-K
LTRN
Lantern Pharma Inc
20 Oct 23
Other Events
5:25pm
10-Q
2023 Q2
LTRN
Lantern Pharma Inc
Quarterly report
9 Aug 23
4:05pm